When it comes to brain tumor awareness, I do not think that anyone can argue with the fact that there are many therapies to take into consideration. You want to make sure that these growths are targeted, which is something that cannot be done unless the best procedures are set in place. What can be said about the ICT-107 vaccine, you may wonder? Judging from a recent report, it seems as though this one may be able to prove especially strong when it comes to survival rates amongst patients.
An article on Medical News Today went into detail about this particular matter and I do not think that it is hard to see why. Keep in mind that glioblastoma multiforme is the condition being targeted here, which is something that can be said about most other procedures related to brain tumor awareness. The level of aggression seen in this particular condition is something that no other tumor type can match. As a result, organizations along the lines of Voices against Brain Cancer are going to focus on it.
From what I have seen, this condition is one in which the cancerous cells seem to regenerate rather quickly. The cells are ones which feed off of the blood stream in the body, which means that there is a source of nourishment set in place. The American Brain Tumor Association went into detail about this as well as the level of risk that was seen. Even though this condition can come about in anyone, it seems as though said risk increases with men more than women, according to the ABTA.
A study that was done by the Cedars-Sinai Medical Group was one that was able to put the ICT-107 vaccine to use. This would be able to benefit the immune system, as it would direct attention to the cancerous cells within the body. After this was done, a tumor-killing response would follow. Keep in mind that this vaccine is administered only after the typical conditions are met, invasive surgery, chemo, and radiation included. After the vaccine was brought into play three times week at two-week intervals, results would be had.
I think that these particular results were quite positive, as it seems like seven of the sixteen patients that were originally involved could be helped that much more in the long term. Survival rates extended between 60.7 and 82.7 months, which is great for those who consistently bring attention to the matter. In addition, take into account that six of the original patients were said to be "progression-free." They did not have to worry about tumors coming back and the fact that treatment did not have to be followed up on speaks greater volumes.
An article on Medical News Today went into detail about this particular matter and I do not think that it is hard to see why. Keep in mind that glioblastoma multiforme is the condition being targeted here, which is something that can be said about most other procedures related to brain tumor awareness. The level of aggression seen in this particular condition is something that no other tumor type can match. As a result, organizations along the lines of Voices against Brain Cancer are going to focus on it.
From what I have seen, this condition is one in which the cancerous cells seem to regenerate rather quickly. The cells are ones which feed off of the blood stream in the body, which means that there is a source of nourishment set in place. The American Brain Tumor Association went into detail about this as well as the level of risk that was seen. Even though this condition can come about in anyone, it seems as though said risk increases with men more than women, according to the ABTA.
A study that was done by the Cedars-Sinai Medical Group was one that was able to put the ICT-107 vaccine to use. This would be able to benefit the immune system, as it would direct attention to the cancerous cells within the body. After this was done, a tumor-killing response would follow. Keep in mind that this vaccine is administered only after the typical conditions are met, invasive surgery, chemo, and radiation included. After the vaccine was brought into play three times week at two-week intervals, results would be had.
I think that these particular results were quite positive, as it seems like seven of the sixteen patients that were originally involved could be helped that much more in the long term. Survival rates extended between 60.7 and 82.7 months, which is great for those who consistently bring attention to the matter. In addition, take into account that six of the original patients were said to be "progression-free." They did not have to worry about tumors coming back and the fact that treatment did not have to be followed up on speaks greater volumes.
About the Author:
Visit Voices Against Brain Cancer if you're seeking more information about brain tumor awareness and research.